Conférences sur les essais cliniques 2021

VEUILLEZ NOTER QUE LE TEXTE CI-DESSOUS N’EST DISPONIBLE QU’EN ANGLAIS POUR LE MOMENT.

The 5th annual Clinical Trials Conference entitled « Patient Group Pathway Model to Accessing Clinical Trials and Real-World Evidence ». The theme this year was: Revolution, Innovation, Transformation in Cancer Clinical Trials and was held on Nov 16 & 17th. It brought together key stakeholders including researchers, clinical trial networks, patients, patient groups, government agencies and industry to reinforce patient and patient group partnerships among those who advocate for cancer clinical trials in Canada. The overarching goals for the Conference:

image002

DAY 1:

  • Understand how clinical trial models could be adapted to ensure early access to innovations in oncology drugs – regulatory & HTA approvals.
  • Evaluate the impact of the COVID-19 pandemic on the:

    • ways that clinical trials are conducted;
    • future of clinical trials post-COVID-19.

These are the videos and relevant info:

DAY 2:

  • Discuss innovation and modernization in clinical trials with a focus on patient-centricity.
  • Assess the potential for and opportunities for:

    • building a vibrant Canadian life sciences environment;
    • encouraging investment in the Canadian life sciences sector.

Your Content Goes Here

Welcome from CCC President & Conference Objectives | Barry Stein (President & CEO, CCC) and Anne Marie Wright (ESI)

Keynote: To infinity and beyond – 5 years after the cancer moonshot

peakers: Greg Simon, Former President, Biden Cancer Initiative

Revolution in drug discovery and how this impacts clinical trials

Speakers: Jennifer Chan (V.P. Policy, Merck), Alexandra Chambers (Manager, Health Policy and Patient Access, National Oncology Policy, Novartis), Michele Caveen (Sr. Medical Advisor Amgen Canada), Dr. Shurjeel Choudhri (SVP and Head, Medical & Scientific Affairs, Bayer), Dr. Henry Conter (Strategic Healthcare Partner for Oncology, Roche)
Panel Leader: W. Neil Palmer (Senior Strategic Adviser & President Emeritus, PDCI Market Access)

The landscape of change: Disruption and transformation across the cancer care ecosystem

Speakers: Richard Fajzel (CEO, Exactis Innovation) Jack Kitts (CPHIN) Jim Woodgett (President, Terry Fox Marathon of Hope)
Panel Leader: Dr. Aaron Schimmer (UHN, Research)

Day 2

Innovation in clinical trials

Speakers: Victoria Lemieux (Lead of the Blockchain Research Cluster (Blockchain@UBC) at UBC, Chief Information Security & Privacy Officer, Molecular You) Olivier Jérôme (Director Public & Patient Engagement, Catalis) Dr. Kam Kafi (Director of Clinical Strategy & Oncology, Imagia) Dr. Howard Lim (BC Cancer Agency)
Panel Leader: Laszlo Radvanyi (President, OICR)

Session 2: Facilitating the Environment for Innovation (Part 1)

Speakers: Dr. Roxana Alexa (Manager MD, Health Canada) Susan Marlin (President & CEO, Clinical Trials Ontario) Patrick Sullivan (Patient Advocate)
Panel Leader: Stéphanie Michaud (President, BioCanRx)

Session 2: Facilitating the Environment for Innovation (Part 2)

Speakers: Marianne Gandee (Vice President, Patient Solutions & Alliances, Pfizer) Sara Pierson (Director, Patient Recruitment Programs, Pfizer)
Panel Leader: Barry Stein (President & CEO, CCC)

Building a vibrant canadian life sciences environment

Speakers: Jason Field (President & CEO, Life Sciences Ontario) Carl Viel (President & CEO, Quebec International) Anne-Marie Christine Thoft (Special Advisor Life Sciences, Invest in Denmark) Karimah Es Sabar (CEO, Quark Venture)
Panel Leader: Shanil Ebrahim (Partner, Deloitte)